Methods. Immuno-localization of Notch1 was performed during epithelial wound healing in vivo in mouse corneal epithelial debridement wounds and in vitro in primary human corneal epithelial cells following a linear scratch wound. The effects of Notch inhibition, using the γ-secretase inhibitor DAPT or following stable transfection with Notch1-shRNA, was evaluated in a scratch assay and transwell migration assay. Likewise, in vitro adhesion, proliferation and the actin cytoskeleton was examined. The DAPT effect was also evaluated in vivo in a mouse model of corneal epithelial wound healing.
Introduction
The corneal epithelium protects the cornea against pathogen invasion and is essential for maintaining the integrity and clarity of the cornea. It is constantly regenerated by a reservoir of stem and progenitor cells located primarily in the limbal region. Following an injury that leads to the loss of the epithelium, the remaining epithelial cells undergo a programmed repair mechanism to immediately close the defect. 1 This highly coordinated process involves a number of cellular functions including migration, proliferation and differentiation, which in many ways recapitulate the same pathways involved during development. While many of the regulatory mechanisms governing corneal epithelial wound healing have been studied before 2 , the role of Notch signaling, a critical pathway during development, has not been completely defined.
The Notch signaling pathway is a highly conserved network that orchestrates cell-fate decisions in many tissues and organisms. 3, 4 Notch proteins are membrane-bound receptors with corresponding membrane bound ligands, Delta and Jagged. Upon binding of the ligand, the Notch receptor is externally cleaved by a disintegrin and metalloprotease (ADAM) and then internally by the -secretase complex. 5, 6 This releases the Notch intracellular (NotchIC) fragment which in the canonical signaling pathway translocates into the nucleus and associates most commonly with CBF1/RBPJ to trans-activate target genes such as Hairy/Enhancer of Split (Hes). 7, 8 The importance of Notch signaling in the corneal epithelium has been highlighted by several studies. [9] [10] [11] [12] [13] [14] Previously, we reported down-regulation of Notch1 during the initial stages of wound healing in the corneal epithelium. 11 At the time, we correlated this decrease in Notch signaling to the increased proliferative status of the corneal epithelium and proposed a negative correlation between Notch activation and proliferation. However, as shown in the present study, the decrease in Notch1 at the immediate phase of wound healing may in fact be more closely correlated with the increased migratory capacity of corneal epithelial cells. We demonstrated that Notch1 was specifically reduced at the leading edge of a healing corneal epithelium and that exogenously inhibiting Notch enhanced the migration of corneal epithelial cells. We further showed that inhibition of Notch induced changes in the actin cytoskeleton that are consistent with the increased migratory phenotype.
Methods

Corneal epithelial cell culture
Human corneal epithelial cell cultures were initiated from cadaver corneas kindly provided by the Illinois Eye Bank. The limbal rings were treated with Dispase (2 mg/ml) at 37°C for 2 hours to separate the epithelial sheets, then digested in 0.25% trypsin-EDTA for 5-10 minutes. Cells were washed and resuspended in keratinocyte serum-free medium (KSFM;
Invitrogen, location) and plated in collagen coated tissue culture plates. In addition to primary corneal epithelial cells, an SV40 transduced human corneal epithelial cell line (HCE-T) was used for some of the experiments. 15 HCE-T cells were grown in DMEM/F12 (1:1) with 5% fetal bovine serum (FBS).
Immunofluorescence staining and Microscopy
Mouse corneal sections as well as corneal epithelial cells grown on chamber slides were stained according to previously described protocols. 11 The following primary antibodies were used: rabbit polyoclonal anti-Ki-67 (Abcam, Cambridge, MA, dilution1:1000) and anti-Notch1
(Santa Cruz Biotech., Santa Cruz, CA, dilution 1:100) antibodies. For negative control, the sections were incubated with an irrelevant (no epithelial expression of the antigen) rabbit antibody. The sections were examined using a spinning disc confocal microscope (Z1, Carl Zeiss), and photographed with an AxioCam (Carl Zeiss, Thornwood, NY) camera.
Notch1 knockdown in HCE-T cells
HCE-T cells were transduced with GIPZ Lentiviral shRNA viral particles (Open Biosystems, Lafayette, CO) at multiplicity of infection (MOI) of 5. Two human Notch1 shRNA constructs (target sequences ACGGACTGCGTGGACAGCT, AGGTGCAGCCACAAAACTT)
were used with titers of 1.20 X 10 8 and 1.04 X 10 8 transducing units (TU)/ml, respectively. Nonsilencing shRNA was used as negative control and GAPDH shRNA was used as positive control (Open Biosystems). The transduced cells were identified based on GFP expression given the GFP component in the viral vector (CMV-tGFP-IRES-puromycin-shRNA). Two stable transfections of Notch1-shRNA (corresponding to each target sequence) and a stable transfection of non-silencing shRNA was established using puromycin (4 g/ml) treatment for 2-3 weeks (puromycin resistance factor also included in the backbone). Notch1 knockdown was evaluated by RT-PCR and Western blotting.
In vitro scratch assay
Primary human corneal epithelial cells or HCE-T were grown to confluence on collagen coated plates. Primary cells were maintained in KSFM but the calcium was increased to 0.5 mM for 24 hours while HCE-T cells were switched to media with no serum for 24 hours. The cells were exposed to the γ-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-l-alanyl]-Sphenylglycine t-butyl ester (DAPT) (Selleckchem, Houston, TX), 100 nM to 50 M, or vehicle (dimethyl sulfoxide (DMSO), maximum concentration 0.02%) for 12-24 hours before a linear scratch was made using a sterile 200 l pipette. 16 Immediately after the scratch and at 12 and 24 hours images of the scratch area were captured using the Zeiss AxioCam MR digital camera on a Zeiss Axioskop2 light microscope (Carl Zeiss, Germany). The remaining wound area was measured using ImageJ software (NIH) and normalized to time 0 wounds. To minimize the effect of proliferation, experiments were also repeated in primary cells they had been previously treated with mitomycin-C (Bedford laboratories, Bedford, OH) 5 to 10 μg/ml for 3 hours. A scratch assay was also similarly performed in HCE-T stably transfected with Notch1 and nonsilencing shRNA. 
Transwell migration assay
Proliferation assay
The effect of DAPT on cell proliferation was assessed using a thiazolyl blue tetrazolium bromide (MTT, Sigma-Aldrich, St. Louis, MO) assay. Primary human corneal epithelial cells were plated in a 48 well plate at a density of 75,000 per well and grown to 60% confluence. The growth factors were eliminated from the media overnight and the cells were treated with DMSO (0.02%) or DAPT (5 μM) for 24 hours. After complete removal of the media, 20 μl of MTT solution was replaced in each well and incubated at 37 °C for 3 hours; the solution was then removed and 500 μL of DMSO was replaced in each well. The concentration was determined by 7 optical densitometry at the 560 nm wavelength.
The in vitro proliferation rate was also measured by immunofluorescence staining for the proliferation marker, Ki-67. Primary human cells were plated in equal numbers in a 4 well chamber slides and grown to 40 percent confluence then treated in the same fashion with DAPT, or DMSO. The cells were fixed 24 hours later and stained for Ki-67 as described above.
Cell adhesion assay
HCE-T transduced with shRNA and primary human corneal epithelial cells treated with DAPT, Jagged1 or DMSO for 24 hours, were trypsinized and plated equally in a 96 well flat bottom plate coated with fibronectin-collagen plus 3% bovine serum albumin (BSA, Sigma).
After 30 minute incubation at 37 °C, the cell culture media was removed and the plate was washed multiple times with phosphate buffered saline (PBS). The adherent cells were fixed with 100% ethanol then stained with crystal violet after which the absorbance in each well was measured at 590 nm wavelength.
Phalloidin staining
Primary human corneal epithelial cells or shRNA transduced HCE-T cells were cultured to confluence on chamber slides. After serum starvation overnight, a linear scratch was made on the slides. The slides were stained 6 hours after the scratch by the following protocol: after fixation with periodate-lysine-paraformaldehyde (PLP) for 20 minutes, the cells were permeabilized using Tris buffered saline (TBS) and 0.3% Triton X-100 for 5 minutes, washed in PBS 3 times and then incubated in rhodamine-phalloidin (Cytoskeleton Inc, 1:40 dilution in PBS containing 1% BSA) for 20 minutes. After three PBS washes, the slides were mounted using DAPI fluoromount-G medium.
Reverse-transcriptase (RT) Polymerase-Chain Reaction (PCR)
RNA isolation from epithelial cell cultures and form mouse corneal epithelium was performed as previously described. 11 RT reaction was likewise completed as before, followed by PCR for human Notch1, human GAPDH, human Hes1, human β-actin, mouse Hes1 and mouse β-actin (sequences published before 11 otherwise available upon request).
Western blots
Western blots were performed as previously described. 11 The following antibodies were used: rabbit anti-cleaved-Notch1 Val1744 (dilution 1:500), rabbit anti-GAPDH (1:5000) both from Cell Signaling (Danvers, MA). Detection was performed by Image Quant LAS 1040 detection system and quantified using ImageQuant software (Pittsburgh, PA).
Mouse model of corneal epithelial wound healing
Corneal wounding experiments in mice were conducted in compliance with the recommendations of the Association for Research in Vision and Ophthalmology (ARVO). Sixmonth-old C57BL/6J mice were anesthetized with intraperitoneal injection of ketamine (100 mg/kg) and xylazine (5 mg/kg). After applying two drops of topical 0.5% proparacaine, a 2.0 mm area of the central epithelium was demarcated and removed by gentle scraping using a blunt corneal scraper (for Notch1 localization studies a 1.5 mm wound was also used). In the treatment (N=7) or the control (N=7) group, DAPT (20 M) or vehicle (DMSO 0.02%) (20-30 µl) was applied to the cornea every 15 minutes for 2 hours. At 24 hours, the corneas were stained with fluorescein and photographed using a Nikon FS-2 photo-slit lamp with a Nikon D200 camera. Wound sizes were compared to the baseline for each mouse and the percentages of wound closure was measured using ImageJ software.
Results
Notch1is reduced at the leading edge of migrating corneal epithelium
Using immunofluorescence staining, the expression of Notch1 in the mouse corneal epithelium 6 hours after 1.5 mm and 2.0 mm debridement wound was examined. As shown in Primary human corneal epithelial cells grown to confluence were subjected to a scratch wound.
The percentage of cells expressing Notch1 in the leading edge at 12 hours after the scratch was 42% lower compared to baseline (P<0.001) (Fig 1B-D) .
Notch inhibition accelerates human corneal epithelial migration and wound closure
A scratch assay was used to examine the effect of Notch inhibition in human corneal epithelial cells (primary cells and HCE-T). To inhibit Notch signaling broadly, we used the γ-secretase inhibitor DAPT (100 nM to 10 M). The results demonstrated that DAPT 1-10 M consistently accelerated wound closure compared to control (0.02% DMSO) (Fig 2A, B) .
Concentrations less than 1 M had no effect while those above 10 M demonstrated an inhibitory effect (data not shown for concentration above 10 M since toxicity could not be excluded at these higher doses) ( Fig. 2A,B ). Notch inhibition with 10 M DAPT was measured by Western blotting for Notch1IC confirming that Notch had been effectively inhibited (Fig. 2C ).
To examine migration more specifically, HCE-T cells were also subjected to a transwell migration assay. The results demonstrated significantly enhanced migration in cells pretreated with DAPT (218% ± 42%) compared to control (arbitrarily set to 100%) (P < 0.0001). In contrast, Notch activation with Jagged1 appeared to delay migration (80% ± 30%) compared to control but this did not reach statistical significance (P = 0.077). (Fig 2D, E) Since γ-secretase has additional substrates besides Notch that may potentially affect migration, we used Notch1-shRNA to knockdown Notch1 expression more specifically. HCE-T cells were stably transfected with Notch1-shRNA resulting in 66% knockdown of Notch1 by
RT-PCR and reduced Notch1IC by Western blot (Fig 3A, B) . Notch1-shRNA transduced cells demonstrated significantly enhanced scratch wound closure and transwell migration compared to nonsilencing shRNA transduced cells (Fig 3 C-F) . These results were confirmed in a second Notch1-shRNA (different target sequence) transduced cell line which knocked down Notch1 expression by 56% and similarly accelerated migration (data not shown).
Notch Inhibition does not affect cell proliferation
Additional studies were done to determine whether the enhanced wound healing observed with γ-secretase inhibition was due to increased proliferation. First, the scratch assay was repeated in primary cells that had been mitotically inactivated with mitomycin C. The results indicated that DAPT enhanced wound closure with or without mitomycin treatment (data not shown) suggesting that cell proliferation was not a factor for the enhanced wound healing. The effect of DAPT on cell proliferation was further assessed in primary human corneal epithelial cells using both Ki67 staining and MTT assays. As shown in Figure 4 , the proliferation rate was similar in cells with Notch inhibition compared to control. Although there was no difference in the rate of proliferation based on the MTT assay and Ki67 staining, since this was not done in a scratch assay we cannot completely exclude the possibility that Notch inhibition may have also enhanced scratch wound closure by also affecting proliferation. Nonetheless, based on the results of the transwell migration, which is a more specific assay for migration, it appears that Notch inhibition does have an effect on cell migration.
Notch Inhibition reduces and Notch activation increases cell-matrix adhesions
Typically during cell locomotion, cell-matrix adhesions are reduced to allow the cells to migrate. 17 Therefore, we sought to determine the effect of Notch inhibition on corneal epithelial cell-matrix adhesions. Primary human corneal epithelial cells exposed to DAPT, Jagged1 or DMSO were evaluated for their ability to adhere to fibronectin-collagen coated plates. The results revealed that after Notch inhibition, the cells adhered 34.5% less efficiently to the matrix compared to DMSO treated controls (Fig. 5A ). In contrast, Notch activation with Jagged1 caused the cells to become more adherent to the matrix (Fig. 5B ). Notch1-shRNA transduced cells similarly demonstrated reduced adhesion to the matrix compared to non-silencing shRNA transduced cells (Fig 5C) . Such reduction is consistent with the increased migratory capacity of the cells after Notch inhibition.
Notch Inhibition affects the actin cytoskeleton
Given the importance of the cytoskeletal function in cell migration, rhodamine-phalloidin staining was performed to examine the effect of Notch inhibition on the actin structures. As seen in Figure 6 (A-D), DAPT treatment enhanced the formation of lamellipodia in the cells near the healing edge. Lamellipodia are important cytoskeletal structures that contribute to cell migration. [18] [19] [20] In parallel with the more prominent membrane protrusions, the cells also displayed a loss of marginal actin bundle (Fig. 6C, D, asterisks) . The correlation between the loss of marginal actin bundle and enhanced membrane protrusion (e.g. lamellipodia) has been reported before. 20, 21 Examination of the Notch1-shRNA transduced cells similarly demonstrated enhanced lamellipodia near the leading edge compared to non-silencing shRNA (Fig. 6E, F) .
Inhibiting Notch accelerates corneal epithelial wound closure in a murine model
We finally examined the effect of Notch inhibition in an in vivo model of corneal epithelial wound healing. A 2.0 mm corneal epithelial debridement wound was created in mice followed by application of DAPT or vehicle to the cornea for 2 hours. At 24 hours, the corneas treated with DAPT demonstrated a higher percentage area of wound closure compared to DMSO (Fig. 7A-C) . Histologic examination of the proliferation marker Ki67 at 24 hours did not demonstrate any difference between Notch inhibited and DMSO control groups, suggesting that migration was the predominant process affected (Fig. 7D, E) .
Discussion
Corneal epithelial wound healing is a highly coordinated process that involves numerous cell-cell signaling pathways. In this study, we examined the involvement of Notch signaling in corneal epithelial wound healing and found a specific role in epithelial cell migration. Previous studies have primarily focused on the role of Notch in proliferation and differentiation and its role in migration has not been investigated specifically in the cornea. [12] [13] [14] In an earlier study, we had reported an inverse correlation between Notch and epithelial proliferation in corneal epithelial wound healing. 11 However, based on the results of the present study, it appears that the inverse correlation may be more closely associated with migration particularly in the cells near the leading edge. We found that in the first 6 hours after wounding, Notch1 is down-regulated in the leading edge, promoting a more migratory phenotype in these cells.
Our results demonstrating faster migration with Notch inhibition is consistent with previous findings in skin epithelial cells. 22 Dotto and colleagues transfected human skin keratinocytes with a retroviral dominant negative construct to inhibit all canonical Notch 13 signaling and found that Notch inhibited cells had significantly increased migratory behavior both by individual cell velocity measurements and by Matrigel invasion assay. 22 They implicated Rho-ROCK signaling as the mechanism of action.
In another study, Ma et al investigated the effects of Notch activation and inhibition on corneal epithelial wound healing in organ cultured rat eyes. 13 They found that enhancing Notch signaling with a soluble ligand (Jagged-1) retarded wound closure at 24 hours without affecting proliferation, suggesting that migration may have been inhibited. In contrast to our results, they did not find any enhancement in wound closure rate with γ-secretase inhibition. Besides the differences in the experimental models, the difference between our results and theirs may be due to the varying degrees of Notch inhibition. In this study, we carefully examined the various concentrations of γ-secretase inhibitor and found the effective dose for enhancing migration to be 1-10 M, which is a 10 fold lower equivalent dose compared to the specific gamma secretase inhibitor and concentrations used by Ma et al. 13 The lower concentration of the γ-secretase inhibitor used in our study is able to inhibit Notch effectively as shown by the reduced levels of Notch1IC (Fig. 2C) . Using lower concentrations of the γ-secretase inhibitor DAPT is not only advantageous to minimize non-Notch effects, but perhaps because only partial inhibition of Notch would result in enhanced wound healing. Higher concentrations of DAPT were found in our experiments to inhibit wound healing, although we could not exclude the possibility of toxicity. Previous studies have demonstrated that Notch is a highly dosage dependent signaling system such that high levels of Notch activation may have completely different effects compared to low levels of Notch activity. 23, 24 A recent study reported that over-expressing Notch1 in transgenic mice also enhances corneal epithelial wound healing. 14 The investigators developed mice that over-express Notch1IC (active Notch1) in the corneal epithelium and found that in the transgenic mice corneal epithelial debridement wounds healed faster than controls. These results may at first seem to contradict ours, which showed enhanced wound healing with Notch inhibition. However, a different mechanism may underlie the Notch1IC transgenic findings, namely, the transgenic epithelium may exhibit a quicker onset of proliferation compared to control mice. 14 While more studies are needed to dissect the role of Notch in wound healing, based on findings from Lu et al. 14 and ours, one might speculate that Notch1 plays multiple roles involving both migration and proliferation. Further studies are also needed to dissect the role of other Notch receptors (Notch2 and Notch3) in corneal epithelial wound healing.
A novel finding of our study is that Notch inhibition promoted cytoskeletal changes that facilitate cell migration. In particular, Notch inhibited cells demonstrated enhanced lamellipodia along with loss of marginal actin bundle. We hypothesize that these changes are likely mediated through Rho GTPases. As mentioned earlier, a previous study has implicated Rho-ROCK signaling pathway in the enhanced migratory behavior of skin keratinocytes after Notch inhibition. 22 Additional investigations are necessary to determine specific mechanisms by which Notch might regulate Rho-ROCK activity in the corneal epithelium.
In summary, we have implicated Notch signaling in the regulation of corneal epithelial cell migration. Based on current results, we speculate that treatment with agents that inhibit Notch signaling may provide a novel approach for enhancing corneal epithelial migration and wound healing clinically. This is particularly exciting since a number of Notch inhibitors are currently in clinical trials as cancer therapies 25, 26 , making them potentially available for clinical application to the cornea. 
